RCC1 and cancer: As cell cycle arrest-mediated apoptosis is also an attractive drug target for cancer therapy, it is therefore imperative to explore DET and IDET for their potential to target cell cycle regulatory proteins in multiple in vitro and in vivo cancer models; this would make it possible to obtain additional evidence to support the development of these compounds into effective chemotherapeutic drugs.